Detection of BCL-2 RNA in Low Grade Tumours of the Urinary Bladder

Author： Gazzaniga P. Gallucci M. Gradilone A. Gandini O. Vincenzoni A. Gianni W. Naso G. Frati L. Agliano A.M.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.12, 1995-11, pp. : 2119-2120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1271-1277

Spandidos Publications

Access to resources Recommend Favorite

The expression and significance of survivin mRNA in urinary bladder carcinomas

By Wang Haidong Xi Xiaoqing Kong Xianguo Huang Guohua Ge Gen

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 8, 2004-08 ,pp. : 487-490

Springer Publishing Company

Access to resources Recommend Favorite

2. Obesity as a Low-Grade Inflammation

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 18-18

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Bcl-2 and p53 Expressions in Invasive Bladder Cancers

By Kong Gu Shin Ki Yong Oh Young Ha Lee Jong Jin Park Hae Young Woo Young Nam Lee Jung Dal

Acta Oncologica, Vol. 37, Iss. 7-8, 1998-12 ,pp. : 715-720

Informa Healthcare

Access to resources Recommend Favorite

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

By Bajetta Emilio Catena Laura Procopio Giuseppe Dosso Sara Bichisao Ettore Ferrari Leonardo Martinetti Antonia Platania Marco Verzoni Elena Formisano Barbara Bajetta Roberto

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 637-642

Springer Publishing Company

Access to resources Recommend Favorite